Description
In cattle:- treatment of respiratory infections caused by strains of Histophilus somni, Mannheimia haemolytica, Mycoplasma bovis, Pasteurella multocida susceptible to marbofloxacin.- treatment of acute mastitis caused by strains of Escherichia coli susceptible to marbofloxacin during the lactation period. In pigs: – treatment of Postpartum Dysgalactia Syndrome -PDS-(Metritis Mastitis Agalactia syndrome), caused by bacterial strains susceptible to marbofloxacin.
